Skip to content

Clinical trials

Completed Urinary Bladder Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Status: Completed Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20051
20071
20081
20091
20101
20131
20152
20162
20171
20184
20193
20204
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Hoffmann-La Roche2
Trans Tasman Radiation Oncology Group2
Arcus Biosciences, Inc.1
Asieris Pharmaceuticals (AUS) Pty Ltd.1
Astellas Pharma Global Development, Inc.1
Australian and New Zealand Urogenital and Prostate Cancer Trials Group1
Basilea Pharmaceutica1
Boehringer Ingelheim1
Corvus Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms27
Carcinoma, Transitional Cell7
Lung Neoplasms6
Colorectal Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Breast Neoplasms3
Carcinoma, Renal Cell3
Endometrial Neoplasms3
Kidney Neoplasms3
Melanoma3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.